OBJECTIVES The purpose of this study was to determine the mechanistic overlap between paroxysmal and persistent forms of atrial fibrillation (AF), focusing on AF sources as a classification approach.
. An increasingly recognized fact is that PAF patients may do well after PVI even when the pulmonary veins (PVs) have reconnected (5, 6) , suggesting that PVI lesion sets interrupt other mechanisms. Indeed, studies suggest that PAF is a heterogeneous population that may overlap with persistent AF (7), which may have substrate mechanisms remote from the PVs. However, these mechanisms are yet unidentified in PAF.
We hypothesized that patients with recurrent PAF after prior PVI are more likely to have substrates remote from the PVs, and more closely resemble patients with persistent AF than patients with PAF at their first PVI procedure. This may follow for several reasons.
First, patients with recurrent PAF may have peri-PV mechanisms not eliminated at initial ablation. Second, it may be artificial to "dichotomize" populations with PAF and persistent AF given their overlap in true AF burden (7) , left atrial (LA) size, and atrial structural abnormalities (8) . Third, recent mapping of PAF shows substrates in the form of rotors and focal sources remote from the PVs where targeted ablation can eliminate AF acutely and long-term in many centers (9) (10) (11) (12) with different techniques (13) . Moreover, AF sources have now been demonstrated in human optical mapping studies (14) with many similarities to these clinical studies.
We tested our hypothesis by examining electrical substrates of rotors or focal sources, and structural substrates by echocardiography, in patients with PAF at first ablation, recurrent PAF despite prior PVI, and first-time persistent AF ablation in an 11-center prospective observational study.
METHODS
ENROLLMENT AT CONTRIBUTING CENTERS. Between 2012 and 2014, we enrolled 175 patients undergoing AF ablation for routine indications at 11 centers in the United States ( Table 1 ). All studies and data analyses were performed with local institutional review board approval and patients provided written consent for data collection.
PATIENT CLASSIFICATION. We classified the 175 patients prospectively into de novo PAF, redo PAF, and persistent AF groups. PAF was defined as AF that terminates spontaneously or with intervention within 7 days of onset, whereas persistent AF was defined as continuous AF that is sustained >7 days (15). The de 
Zaman et al. Zaman et al. Probabilities below 0.05 were considered significant.
RESULTS
A total of 175 patients were included in the present study; Table 2 summarizes patient characteristics. The distributions of PV and non-PV sources by group are illustrated in Figure 3 . In patients with redo PAF, sources near PVs lay near gaps in prior PV isolation lesion sets or just outside prior lesion sets, such that electrograms were detected to yield sources (e.g., see case in Figure 2 ). Figure 4 illustrates rotor Figure 1 .
Zaman et al. Table 2 ).
ACUTE IMPACT OF ABLATION. The acute impact of ablation is summarized in Table 3 . Acute termination was seen in 83 patients, of which 41% were to AT and 59% to sinus rhythm directly. Zaman et al.
Post-Ablation PAF A P R I L 2 0 1 7 : 3 9 3 -4 0 2 There was a trend toward a difference among the groups in the number of LA sources (p ¼ 0.070) which was somewhat higher in de novo PAF than in the other groups. There was no group difference in the number of RA sources (p ¼ 0.541). Abbreviations as in Figures 1 and 3 . Redo PAF (n ¼ 38) 24 (64%) 15 9 Persistent AF (n ¼ 96) 32 (33%) 16 16 Values are n (%).
AT ¼ atrial tachycardia; PAF ¼ paroxysmal atrial fibrillation; SR ¼ sinus rhythm. LA size was higher only in the persistent AF group, despite the electrophysiological differences in this study. Mean AE SEM. Abbreviations as in Figures 1 and 3 .
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Post-Ablation PAF A P R I L 2 0 1 7 : 3 9 3 -4 0 2 de novo from redo PAF, which shared AF source distributions and characteristics with persistent AF. (27) . Atrial CMR imaging using delayed enhancement CMR also reveals a wide spectrum of fibrotic substrates that do not conform to current classification schemes based on arbitrary time cut offs. It is hoped such delineation of functional substrates will allow for patient-tailored risk stratification to improve outcomes (28) .
FUTURE DIRECTIONS. These data contribute to the discussion on how to improve the results from PV antral isolation. This is timely. Recent trials show that empiric linear ablation or ablation of complex fractionated electrograms may not improve the results of PV isolation in persistent AF patients (1, 29, 30) . Success in PAF is limited to w65% at 1 year and w50% at 2 years with PVI by cryoballoon or radiofrequency energy using force-sensing catheters More generally, the current study did not prospectively randomize substrates to ablation or nonablation;
however, such a study is also underway. Echocardiographic indices of structure are increasingly being replaced by CMR, which is more widely available now, and neither LA volume data nor computerized tomographic data were universally available from all sites.
Echocardiographic data were reported from clinical records at each site, not from a core lab. Further electrophysiological characterization with voltage or fractionation indices would be attenuated by prior ablation in redo PAF, and was not performed.
CONCLUSIONS
Across 11 U.S. centers, we found that PAF patients at repeat ablation are electrically more similar to patients with persistent AF with numerous extra-PV sources than to PAF patients at their first ablation, despite similar LA size. Our findings motivate studies to further define "functional substrates" and motivate trials to test the benefit of substrate ablation over repeat PVI in patients at repeat procedures.
These findings may also help improve knowledge of AF progression and improve clinical outcomes.
